+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Targeted Genome Analysis Kits Market by Sequencing Kits (Next Generation Sequencing Kits, Sanger Sequencing Kits), Qpcr Kits (Dye Qpcr Kits, Probe Qpcr Kits), Microarray Kits, Hybridization Kits - Global Forecast 2025-2030- Product Image
Targeted Genome Analysis Kits Market by Sequencing Kits (Next Generation Sequencing Kits, Sanger Sequencing Kits), Qpcr Kits (Dye Qpcr Kits, Probe Qpcr Kits), Microarray Kits, Hybridization Kits - Global Forecast 2025-2030- Product Image
New

Targeted Genome Analysis Kits Market by Sequencing Kits (Next Generation Sequencing Kits, Sanger Sequencing Kits), Qpcr Kits (Dye Qpcr Kits, Probe Qpcr Kits), Microarray Kits, Hybridization Kits - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6122186
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Precision medicine and advanced genomics have emerged as cornerstones of modern healthcare, with targeted genome analysis kits acting as critical enablers for research and diagnostics. These kits facilitate high-throughput sequencing, real-time quantification, and hybridization techniques, thereby accelerating genetic discovery and clinical application. As the pace of innovation intensifies, stakeholders across academic, pharmaceutical, and clinical laboratory environments are seeking robust solutions that deliver both depth and accuracy in genomic profiling. Consequently, understanding the current landscape of targeted genome analysis kits has become imperative for organizations aiming to optimize research pipelines and enhance diagnostic workflows.

The development of next generation sequencing technologies, coupled with refinements in qPCR and microarray platforms, has expanded the toolkit available to genomic scientists. This diversification has empowered laboratories to tailor kit selection based on specific research objectives, sample types, and throughput requirements. Transitioning from broad exploratory studies to focused diagnostic assays demands not only the right reagents and protocols but also deep insights into performance benchmarks across different kit categories. Accordingly, this executive summary offers a structured introduction that lays the groundwork for deeper analysis of market transformations, regulatory influences, segmentation dynamics, regional variances, and key industry players shaping the field today.

Exploring How Cutting-Edge Technological Innovations and Regulatory Advances Are Reshaping Genomic Analysis Workflows

Recent years have witnessed a paradigm shift propelled by technological breakthroughs, driving unprecedented capabilities in genomic analysis. Emerging chemistries and microfluidic integration have enhanced sensitivity and specificity, enabling researchers to detect low‐frequency variants and transcriptomic signatures with remarkable precision. In parallel, improvements in automation and sample preparation workflows have substantially reduced hands-on time, making high‐throughput sequencing and quantitative PCR more accessible to mid-sized and smaller laboratories. These technological shifts are fostering a new era of distributed genomic analysis, where centralized sequencing hubs coexist with decentralized point-of-care platforms.

Meanwhile, bioinformatics tools have evolved to manage the deluge of data generated by advanced kits. Cloud-based pipelines and AI-driven variant calling algorithms facilitate rapid interpretation of complex genomic profiles. As a result, the integration of laboratory-scale innovations with robust data analytics has created a feedback loop that continuously refines kit design and performance. Regulatory agencies, recognizing these advancements, are streamlining approval pathways for companion diagnostic kits tied to targeted therapies, further accelerating adoption rates. Consequently, the market is transitioning from volume-driven sequencing experiments to high-value, clinically relevant applications, signaling a transformative shift that will underpin next-generation precision medicine initiatives.

Analyzing the Far-Reaching Effects of the 2025 United States Tariff Policy on Supply Chain Strategies and Cost Structures in Genomic Kits

In anticipation of tariff adjustments slated for implementation in 2025, domestic manufacturers and importers of genomic analysis kits are reevaluating supply chain configurations to mitigate cost pressures. Variable levy structures have introduced additional complexities, particularly for components sourced from key export markets. As duties increase on specialized reagents and proprietary polymerases, production costs for both sequencing and qPCR kits face upward trajectory. To counterbalance these effects, several vendors are diversifying their procurement channels, forging new partnerships in low-tariff regions and investing in vertically integrated manufacturing capabilities.

These strategic moves are accelerating localization efforts, prompting key players to establish or expand production facilities within the United States. While short-term cost escalations have necessitated price adjustments for end users, mid-term benefits are anticipated from reduced logistics expenses and enhanced supply resilience. Despite these protective measures, laboratories dependent on imported hybridization arrays and microfluidic components may still encounter periodic supply disruptions and variant pricing structures. Consequently, tariff impacts are acting as a catalyst for both innovation in domestic kit formulation and reevaluation of long-term sourcing strategies across the genomics ecosystem.

Unveiling Strategic Differentiation Across Sequencing qPCR Microarray and Hybridization Kit Segments to Guide Tailored Research Applications

Segmentation analysis reveals distinct performance trajectories across core kit categories. In sequencing, next generation platforms-spanning amplicon, exome, and whole genome applications-are driving high-throughput projects, while traditional Sanger approaches employing capillary and dideoxy chemistries remain integral for targeted validation workflows. The qPCR domain is characterized by a dichotomy between dye-based formats, featuring EvaGreen and SYBR Green systems, and probe-based assays such as molecular beacon and TaqMan technologies that deliver enhanced specificity for clinical diagnostics. Microarray offerings further diversify the toolkit: DNA microarrays encompassing comparative genomic hybridization arrays and SNP genotyping arrays support genome-wide variation studies, whereas RNA microarrays used for expression profiling and miRNA analysis enable transcriptomic insights.

Hybridization kits complete the landscape, with FISH protocols incorporating direct and indirect labeling techniques coexisting alongside microchip hybridization solutions and traditional southern blot kits. Each segmentation tier is governed by unique validation requirements, regulatory considerations, and throughput demands, underscoring the necessity for end users to align kit selection with project scope, budget constraints, and desired data resolution. These segmentation insights affirm that both established and emerging technologies will continue to coexist, catering to diverse research and diagnostic imperatives.

Illuminating Regional Dynamics in Genomic Kit Adoption across the Americas Europe Middle East Africa and Asia Pacific

Geographically, the market exhibits nuanced adoption patterns aligned with regional research priorities and healthcare infrastructure maturity. In the Americas, robust funding commitments from academic institutions and government agencies have propelled large-scale sequencing initiatives and precision oncology trials. Consequently, demand for high-throughput kits and automated workflows remains strong, supported by well-established distribution networks and localized technical support services.

Across Europe, the Middle East & Africa region, a heterogeneous landscape emerges. Western Europe continues to lead in companion diagnostic approvals and translational research, whereas the Middle East and Africa are witnessing growing investments in genomic medicine, particularly for infectious disease surveillance and population genetics studies. Collaborative public-private partnerships are increasingly driving kit adoption, with an emphasis on standardized protocols and capacity-building initiatives.

In Asia-Pacific, rapid expansion of biotechnology hubs and rising healthcare expenditures are fueling demand for both cost-effective and high-precision genomic assays. Markets in East Asia are distinguished by strong domestic kit manufacturers that complement imported premium products, while Southeast Asia demonstrates burgeoning interest in point-of-care qPCR solutions and decentralized sequencing platforms suited to regional epidemiological challenges.

Profiling Market Leaders and Innovators Driving Collaborative Development of Comprehensive Genomic Kit Ecosystems

Leading organizations continue to shape the competitive terrain through strategic innovation and partnership models. Key global biotech firms have intensified research collaborations with academic consortia to co-develop application-specific panels and reagents, accelerating time to market for specialized kits. Meanwhile, emerging players leverage agile development cycles to introduce niche solutions, such as multiplexed qPCR systems designed for real-time pathogen detection and targeted oncology panels optimized for liquid biopsy applications.

Several prominent entities have also pursued vertical integration strategies, acquiring reagent manufacturers and bioinformatics service providers to offer end-to-end genomic workflows. This consolidation trend is fostering streamlined customer experiences and reinforcing customer loyalty through bundled service offerings. In parallel, technology alliances have become more prevalent, with instrument manufacturers and reagent developers synchronizing product roadmaps to ensure compatibility and performance benchmarks. As the industry evolves, these collaborative ecosystems are reinforcing the value proposition of comprehensive genomic solutions, ensuring that kit providers remain responsive to evolving research and clinical requirements.

Actionable Strategies for Industry Stakeholders to Enhance Adaptability and Foster Collaborative Growth in Genomic Kit Solutions

To navigate the evolving landscape and capitalize on emerging opportunities, industry leaders should prioritize adaptive portfolio strategies that balance broad-based kit offerings with specialized, high-margin applications. Establishing agile manufacturing frameworks will be essential for responding to fluctuating tariff regimes and dynamic customer demands. In addition, investing in modular reagent design and scalable production streams can expedite launch cycles for next generation assays while mitigating supply chain vulnerabilities.

Collaborative engagements with clinical networks and research consortia should be expanded to co-create validation studies and real-world performance datasets, thereby reinforcing trust and driving widespread kit adoption. Furthermore, forging strategic alliances in underserved regions can unlock new growth avenues; leveraging localized regulatory expertise and distribution partnerships will be crucial for market penetration. Finally, embedding advanced analytics and AI-enabled data services within kit offerings will differentiate suppliers by enabling turnkey interpretation workflows, fostering long-term customer relationships through integrated support and value-added insights.

Transparent Overview of the Comprehensive Primary and Secondary Research Process Underlying the Genome Kit Market Analysis

This analysis is underpinned by a rigorous research framework combining primary interviews with thought leaders, end users, and regulatory experts across major geographies. Secondary sources included peer-reviewed publications, patent databases, and technical specifications from leading kit developers. Market segmentation was validated through cross-referencing supply chain data and product release histories, ensuring comprehensive coverage of emerging technologies and legacy platforms.

Quantitative data points were corroborated through anonymized sales channel insights and facility site visits to manufacturing centers specializing in reagent formulation and quality control processes. A multi-layered approach to data triangulation minimized bias and enhanced the reliability of cost structure and regional adoption analyses. The resulting synthesis provides a holistic view of the targeted genome analysis kits market, equipping stakeholders with actionable intelligence grounded in robust empirical evidence.

Synthesizing Key Findings and Forward-Looking Perspectives on the Evolution of Targeted Genome Analysis Kits

The targeted genome analysis kit landscape is poised for sustained evolution, driven by synergistic advances in sequencing, qPCR, microarray, and hybridization platforms. Technological innovation, regulatory adaptation, and shifting supply chain paradigms are collectively reshaping how researchers and clinicians approach genomic profiling. Segmentation dynamics underscore the coexistence of high-throughput and niche solutions, while regional insights highlight differentiated adoption trajectories tied to funding frameworks and healthcare priorities.

In this context, market participants that can harmonize integrated kit portfolios with modular, AI-enabled data services will secure competitive advantage. Strategic partnerships and agile manufacturing will be vital for navigating cost pressures and tariff complexities. As the genomics field transitions toward precision diagnostics and personalized therapies, the ability to deliver validated, high-performance kits across diverse applications will remain the cornerstone of industry leadership and scientific progress.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Sequencing Kits
    • Next Generation Sequencing Kits
      • Amplicon Sequencing Kits
      • Exome Sequencing Kits
      • Whole Genome Sequencing Kits
    • Sanger Sequencing Kits
      • Capillary Sequencing Kits
      • Dideoxy Sequencing Kits
  • Qpcr Kits
    • Dye Qpcr Kits
      • EvaGreen Kits
      • Sybr Green Kits
    • Probe Qpcr Kits
      • Molecular Beacon Kits
      • TaqMan Kits
  • Microarray Kits
    • Dna Microarray Kits
      • Comparative Genomic Hybridization Arrays
      • Snp Genotyping Arrays
    • Rna Microarray Kits
      • Expression Profiling Arrays
      • Mirna Arrays
  • Hybridization Kits
    • Fish Kits
      • Direct Labeling Kits
      • Indirect Labeling Kits
    • Microchip Hybridization Kits
    • Southern Blot Kits
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • BGI Genomics Co., Ltd.
  • Pacific Biosciences of California, Inc.
  • Oxford Nanopore Technologies Ltd.
  • PerkinElmer, Inc.
  • Eurofins Scientific SE

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of single-cell multiomics kits integrating transcriptome and proteome analysis
5.2. Introduction of CRISPR-based targeted sequencing kits for rapid gene editing validation
5.3. Adoption of AI-driven bioinformatics pipelines enhancing variant interpretation accuracy
5.4. Shift towards microfluidics-enabled automated prep workflows reducing hands-on time
5.5. Growth in personalized oncology panels targeting tumor mutation profiling for immunotherapy
5.6. Emergence of portable nanopore sequencing kits for field-based pathogen surveillance studies
5.7. Development of low-cost blood-based kits for noninvasive prenatal and genetic disorder screening
5.8. Integration of antimicrobial resistance gene panels in environmental and clinical surveillance kits
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Targeted Genome Analysis Kits Market, by Sequencing Kits
8.1. Introduction
8.2. Next Generation Sequencing Kits
8.2.1. Amplicon Sequencing Kits
8.2.2. Exome Sequencing Kits
8.2.3. Whole Genome Sequencing Kits
8.3. Sanger Sequencing Kits
8.3.1. Capillary Sequencing Kits
8.3.2. Dideoxy Sequencing Kits
9. Targeted Genome Analysis Kits Market, by Qpcr Kits
9.1. Introduction
9.2. Dye Qpcr Kits
9.2.1. EvaGreen Kits
9.2.2. Sybr Green Kits
9.3. Probe Qpcr Kits
9.3.1. Molecular Beacon Kits
9.3.2. TaqMan Kits
10. Targeted Genome Analysis Kits Market, by Microarray Kits
10.1. Introduction
10.2. Dna Microarray Kits
10.2.1. Comparative Genomic Hybridization Arrays
10.2.2. Snp Genotyping Arrays
10.3. Rna Microarray Kits
10.3.1. Expression Profiling Arrays
10.3.2. Mirna Arrays
11. Targeted Genome Analysis Kits Market, by Hybridization Kits
11.1. Introduction
11.2. Fish Kits
11.2.1. Direct Labeling Kits
11.2.2. Indirect Labeling Kits
11.3. Microchip Hybridization Kits
11.4. Southern Blot Kits
12. Americas Targeted Genome Analysis Kits Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Targeted Genome Analysis Kits Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Targeted Genome Analysis Kits Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Illumina, Inc.
15.3.2. Thermo Fisher Scientific Inc.
15.3.3. QIAGEN N.V.
15.3.4. Agilent Technologies, Inc.
15.3.5. F. Hoffmann-La Roche Ltd.
15.3.6. BGI Genomics Co., Ltd.
15.3.7. Pacific Biosciences of California, Inc.
15.3.8. Oxford Nanopore Technologies Ltd.
15.3.9. PerkinElmer, Inc.
15.3.10. Eurofins Scientific SE
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. TARGETED GENOME ANALYSIS KITS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SEQUENCING KITS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SEQUENCING KITS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY QPCR KITS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY QPCR KITS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MICROARRAY KITS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MICROARRAY KITS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HYBRIDIZATION KITS, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HYBRIDIZATION KITS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. TARGETED GENOME ANALYSIS KITS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. TARGETED GENOME ANALYSIS KITS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. TARGETED GENOME ANALYSIS KITS MARKET: RESEARCHAI
FIGURE 24. TARGETED GENOME ANALYSIS KITS MARKET: RESEARCHSTATISTICS
FIGURE 25. TARGETED GENOME ANALYSIS KITS MARKET: RESEARCHCONTACTS
FIGURE 26. TARGETED GENOME ANALYSIS KITS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. TARGETED GENOME ANALYSIS KITS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY AMPLICON SEQUENCING KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY AMPLICON SEQUENCING KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY EXOME SEQUENCING KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY EXOME SEQUENCING KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY WHOLE GENOME SEQUENCING KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY WHOLE GENOME SEQUENCING KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SANGER SEQUENCING KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SANGER SEQUENCING KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY CAPILLARY SEQUENCING KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY CAPILLARY SEQUENCING KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DIDEOXY SEQUENCING KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DIDEOXY SEQUENCING KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SANGER SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SANGER SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY QPCR KITS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY QPCR KITS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DYE QPCR KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DYE QPCR KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY EVAGREEN KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY EVAGREEN KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SYBR GREEN KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SYBR GREEN KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DYE QPCR KITS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DYE QPCR KITS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PROBE QPCR KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PROBE QPCR KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MOLECULAR BEACON KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MOLECULAR BEACON KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY TAQMAN KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY TAQMAN KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PROBE QPCR KITS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PROBE QPCR KITS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MICROARRAY KITS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MICROARRAY KITS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA MICROARRAY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA MICROARRAY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COMPARATIVE GENOMIC HYBRIDIZATION ARRAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COMPARATIVE GENOMIC HYBRIDIZATION ARRAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SNP GENOTYPING ARRAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SNP GENOTYPING ARRAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA MICROARRAY KITS, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA MICROARRAY KITS, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA MICROARRAY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA MICROARRAY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY EXPRESSION PROFILING ARRAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY EXPRESSION PROFILING ARRAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MIRNA ARRAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MIRNA ARRAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA MICROARRAY KITS, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA MICROARRAY KITS, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HYBRIDIZATION KITS, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HYBRIDIZATION KITS, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY FISH KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY FISH KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DIRECT LABELING KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DIRECT LABELING KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INDIRECT LABELING KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INDIRECT LABELING KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY FISH KITS, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY FISH KITS, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MICROCHIP HYBRIDIZATION KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MICROCHIP HYBRIDIZATION KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SOUTHERN BLOT KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SOUTHERN BLOT KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SANGER SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SANGER SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY QPCR KITS, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY QPCR KITS, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DYE QPCR KITS, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DYE QPCR KITS, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PROBE QPCR KITS, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PROBE QPCR KITS, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MICROARRAY KITS, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MICROARRAY KITS, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA MICROARRAY KITS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA MICROARRAY KITS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA MICROARRAY KITS, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA MICROARRAY KITS, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HYBRIDIZATION KITS, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HYBRIDIZATION KITS, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY FISH KITS, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY FISH KITS, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SANGER SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SANGER SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY QPCR KITS, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY QPCR KITS, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DYE QPCR KITS, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DYE QPCR KITS, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PROBE QPCR KITS, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PROBE QPCR KITS, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MICROARRAY KITS, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MICROARRAY KITS, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA MICROARRAY KITS, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA MICROARRAY KITS, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA MICROARRAY KITS, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA MICROARRAY KITS, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HYBRIDIZATION KITS, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HYBRIDIZATION KITS, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY FISH KITS, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY FISH KITS, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 127. CANADA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 128. CANADA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 129. CANADA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 130. CANADA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 131. CANADA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SANGER SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 132. CANADA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SANGER SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 133. CANADA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY QPCR KITS, 2018-2024 (USD MILLION)
TABLE 134. CANADA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY QPCR KITS, 2025-2030 (USD MILLION)
TABLE 135. CANADA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DYE QPCR KITS, 2018-2024 (USD MILLION)
TABLE 136. CANADA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DYE QPCR KITS, 2025-2030 (USD MILLION)
TABLE 137. CANADA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PROBE QPCR KITS, 2018-2024 (USD MILLION)
TABLE 138. CANADA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PROBE QPCR KITS, 2025-2030 (USD MILLION)
TABLE 139. CANADA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MICROARRAY KITS, 2018-2024 (USD MILLION)
TABLE 140. CANADA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MICROARRAY KITS, 2025-2030 (USD MILLION)
TABLE 141. CANADA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA MICROARRAY KITS, 2018-2024 (USD MILLION)
TABLE 142. CANADA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA MICROARRAY KITS, 2025-2030 (USD MILLION)
TABLE 143. CANADA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA MICROARRAY KITS, 2018-2024 (USD MILLION)
TABLE 144. CANADA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA MICROARRAY KITS, 2025-2030 (USD MILLION)
TABLE 145. CANADA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HYBRIDIZATION KITS, 2018-2024 (USD MILLION)
TABLE 146. CANADA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HYBRIDIZATION KITS, 2025-2030 (USD MILLION)
TABLE 147. CANADA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY FISH KITS, 2018-2024 (USD MILLION)
TABLE 148. CANADA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY FISH KITS, 2025-2030 (USD MILLION)
TABLE 149. MEXICO TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 150. MEXICO TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 151. MEXICO TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 152. MEXICO TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 153. MEXICO TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SANGER SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 154. MEXICO TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SANGER SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 155. MEXICO TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY QPCR KITS, 2018-2024 (USD MILLION)
TABLE 156. MEXICO TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY QPCR KITS, 2025-2030 (USD MILLION)
TABLE 157. MEXICO TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DYE QPCR KITS, 2018-2024 (USD MILLION)
TABLE 158. MEXICO TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DYE QPCR KITS, 2025-2030 (USD MILLION)
TABLE 159. MEXICO TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PROBE QPCR KITS, 2018-2024 (USD MILLION)
TABLE 160. MEXICO TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PROBE QPCR KITS, 2025-2030 (USD MILLION)
TABLE 161. MEXICO TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MICROARRAY KITS, 2018-2024 (USD MILLION)
TABLE 162. MEXICO TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MICROARRAY KITS, 2025-2030 (USD MILLION)
TABLE 163. MEXICO TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA MICROARRAY KITS, 2018-2024 (USD MILLION)
TABLE 164. MEXICO TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA MICROARRAY KITS, 2025-2030 (USD MILLION)
TABLE 165. MEXICO TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA MICROARRAY KITS, 2018-2024 (USD MILLION)
TABLE 166. MEXICO TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA MICROARRAY KITS, 2025-2030 (USD MILLION)
TABLE 167. MEXICO TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HYBRIDIZATION KITS, 2018-2024 (USD MILLION)
TABLE 168. MEXICO TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HYBRIDIZATION KITS, 2025-2030 (USD MILLION)
TABLE 169. MEXICO TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY FISH KITS, 2018-2024 (USD MILLION)
TABLE 170. MEXICO TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY FISH KITS, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SANGER SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SANGER SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY QPCR KITS, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY QPCR KITS, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DYE QPCR KITS, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DYE QPCR KITS, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PROBE QPCR KITS, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PROBE QPCR KITS, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MICROARRAY KITS, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MICROARRAY KITS, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA MICROARRAY KITS, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA MICROARRAY KITS, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA MICROARRAY KITS, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA MICROARRAY KITS, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HYBRIDIZATION KITS, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HYBRIDIZATION KITS, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY FISH KITS, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY FISH KITS, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SANGER SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SANGER SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY QPCR KITS, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY QPCR KITS, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DYE QPCR KITS, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DYE QPCR KITS, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PROBE QPCR KITS, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PROBE QPCR KITS, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MICROARRAY KITS, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MICROARRAY KITS, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA MICROARRAY KITS, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA MICROARRAY KITS, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA MICROARRAY KITS, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA MICROARRAY KITS, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HYBRIDIZATION KITS, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HYBRIDIZATION KITS, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY FISH KITS, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY FISH KITS, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SANGER SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SANGER SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY QPCR KITS, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY QPCR KITS, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DYE QPCR KITS, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DYE QPCR KITS, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PROBE QPCR KITS, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PROBE QPCR KITS, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MICROARRAY KITS, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MICROARRAY KITS, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA MICROARRAY KITS, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA MICROARRAY KITS, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA MICROARRAY KITS, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA MICROARRAY KITS, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HYBRIDIZATION KITS, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HYBRIDIZATION KITS, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY FISH KITS, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY FISH KITS, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SANGER SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SANGER SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY QPCR KITS, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY QPCR KITS, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DYE QPCR KITS, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DYE QPCR KITS, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PROBE QPCR KITS, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PROBE QPCR KITS, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MICROARRAY KITS, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MICROARRAY KITS, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA MICROARRAY KITS, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA MICROARRAY KITS, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA MICROARRAY KITS, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA MICROARRAY KITS, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HYBRIDIZATION KITS, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HYBRIDIZATION KITS, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY FISH KITS, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY FISH KITS, 2025-2030 (USD MILLION)
TABLE 261. GERMANY TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 262. GERMANY TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 263. GERMANY TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 264. GERMANY TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 265. GERMANY TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SANGER SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 266. GERMANY TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SANGER SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 267. GERMANY TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY QPCR KITS, 2018-2024 (USD MILLION)
TABLE 268. GERMANY TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY QPCR KITS, 2025-2030 (USD MILLION)
TABLE 269. GERMANY TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DYE QPCR KITS, 2018-2024 (USD MILLION)
TABLE 270. GERMANY TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DYE QPCR KITS, 2025-2030 (USD MILLION)
TABLE 271. GERMANY TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PROBE QPCR KITS, 2018-2024 (USD MILLION)
TABLE 272. GERMANY TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PROBE QPCR KITS, 2025-2030 (USD MILLION)
TABLE 273. GERMANY TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MICROARRAY KITS, 2018-2024 (USD MILLION)
TABLE 274. GERMANY TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MICROARRAY KITS, 2025-2030 (USD MILLION)
TABLE 275. GERMANY TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA MICROARRAY KITS, 2018-2024 (USD MILLION)
TABLE 276. GERMANY TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA MICROARRAY KITS, 2025-2030 (USD MILLION)
TABLE 277. GERMANY TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA MICROARRAY KITS, 2018-2024 (USD MILLION)
TABLE 278. GERMANY TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA MICROARRAY KITS, 2025-2030 (USD MILLION)
TABLE 279. GERMANY TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HYBRIDIZATION KITS, 2018-2024 (USD MILLION)
TABLE 280. GERMANY TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HYBRIDIZATION KITS, 2025-2030 (USD MILLION)
TABLE 281. GERMANY TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY FISH KITS, 2018-2024 (USD MILLION)
TABLE 282. GERMANY TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY FISH KITS, 2025-2030 (USD MILLION)
TABLE 283. FRANCE TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 284. FRANCE TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 285. FRANCE TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 286. FRANCE TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 287. FRANCE TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SANGER SEQUENCING KITS, 2018-2024 (USD MILLION)
TABLE 288. FRANCE TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SANGER SEQUENCING KITS, 2025-2030 (USD MILLION)
TABLE 289. FRANCE TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY QPCR KITS, 2018-2024 (USD MILLION)
TABLE 290. FRANCE TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY QPCR KITS, 2025-2030 (USD MILLION)
TABLE 291. FRANCE TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DYE QPCR KITS, 2018-2024 (USD MILLION)
TABLE 292. FRANCE TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DYE QPCR KITS, 2025-2030 (USD MILLION)
TABLE 293. FRANCE TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PROBE QPCR KITS, 2018-2024 (USD MILLION)
TABLE 294. FRANCE TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PROBE QPCR

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Targeted Genome Analysis Kits market report include:
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • BGI Genomics Co., Ltd.
  • Pacific Biosciences of California, Inc.
  • Oxford Nanopore Technologies Ltd.
  • PerkinElmer, Inc.
  • Eurofins Scientific SE

Related Topics

Related Reports

Genomic Biomarker Market by Product Type (Instruments, Reagents & Kits, Services), Technology (Mass Spectrometry, Microarray, Next-Generation Sequencing), Application, End User, Biomarker Type - Global Forecast 2025-2030 - Product Image

Genomic Biomarker Market by Product Type (Instruments, Reagents & Kits, Services), Technology (Mass Spectrometry, Microarray, Next-Generation Sequencing), Application, End User, Biomarker Type - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
NGS Sample Preparation Market by Product Type (Amplification Kits, Fragmentation and Size Selection, Library Prep Kits), Application (Epigenetics, Metagenomics, Rna Sequencing), Technology, Workflow Step, End User - Global Forecast 2025-2030 - Product Image

NGS Sample Preparation Market by Product Type (Amplification Kits, Fragmentation and Size Selection, Library Prep Kits), Application (Epigenetics, Metagenomics, Rna Sequencing), Technology, Workflow Step, End User - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Genome Testing Market by Product Type (Instruments, Kits, Reagents & Consumables), Technology (Microarray, Next Generation Sequencing, PCR), Application, End User, Service Type - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030 - Product Image

Genome Testing Market by Product Type (Instruments, Kits, Reagents & Consumables), Technology (Microarray, Next Generation Sequencing, PCR), Application, End User, Service Type - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global, United States Global, United States
From
Mutation Detection Kits In Genome Editing Market by Technology (Cripsr, Meaganuclease, Talen), Detection Method (High Resolution Melt Analysis, Ngs, Pcr), Application, End User, Distribution Channel, Workflow Stage - Global Forecast 2025-2030 - Product Image

Mutation Detection Kits In Genome Editing Market by Technology (Cripsr, Meaganuclease, Talen), Detection Method (High Resolution Melt Analysis, Ngs, Pcr), Application, End User, Distribution Channel, Workflow Stage - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Microarray Kits Market by Application (Comparative Genomic Hybridization, Gene Expression Profiling, Mirna Profiling), Product Type (Array Based, Bead Based), End User, Technology Platform, Sample Type, Probe Type - Global Forecast 2025-2030 - Product Image

Microarray Kits Market by Application (Comparative Genomic Hybridization, Gene Expression Profiling, Mirna Profiling), Product Type (Array Based, Bead Based), End User, Technology Platform, Sample Type, Probe Type - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.